Moffitt Cancer Center has been awarded a four-year, $3 million grant from the Department of Defense’s Congressionally Directed Medical Research Programs to develop new treatments for rare melanomas, including uveal melanoma. The grant will fund two projects aimed at advancing targeted alpha-particle therapies.
Tag: Eye Cancer
Grant from Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer
Research to Prevent Blindness and Castle Biosciences today announced that they are partnering to increase opportunities for medical students to gain research experiences, specifically in the field of ocular cancer.